TP53 Mutational signature for aristolochic acid: An environmental carcinogen

International Journal of Cancer

Volumn 129, Issue 6, 2011, Pages 1532-1536

  Moriya, Masaaki ^a   Slade, Neda ^b   Brdar, Branko ^b   Medverec, Zvonimir ^c   Tomic, Karla ^c   Jelaković, Bojan ^d,e   Wu, Lin ^f   Truong, Sim ^f   Fernandes, Andrea ^a   Grollman, Arthur P ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

^d KBC Zagreb   (Croatia)

^e Croatian Center for Endemic Nephropathy   (Croatia)

^f ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

aristolochic acid; Balkan endemic nephropathy; signature mutation; TP53; urothelial cancer

Indexed keywords

ADENINE; ARISTOLOCHIC ACID;

ALTERNATIVE RNA SPLICING; ARTICLE; CODON; CONTROLLED STUDY; CROATIA; ENDEMIC DISEASE; EXCISION REPAIR; GENE SIGNATURE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; INTRON; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE TP53; PRIORITY JOURNAL; SERBIA; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

ARISTOLOCHIC ACIDS; CARCINOGENS, ENVIRONMENTAL; CARCINOMA, TRANSITIONAL CELL; DIET; GENES, P53; HUMANS; MUTATION; UROTHELIUM;

EID: 79960902308     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26077     Document Type: Article

References (25)

1. Djukanović L, Radovanović Z,. Balkan endemic nephropathy. In:, De Broe ME, Porter GA, Bennett WM, Verpooten GA, eds. Clinical nephrotoxins, 2nd edn. Amsterdam: Kluwere Pubs, 2003. 588-601.
2. Petronić V,. Tumors of the upper urothelium and endemic nephropathy. In:, Radovanović Z, Sindić M, Polenaković M, Djukanović L, Petronić V,. Endemic nephropathy. Belgrade Serbia: Institute for Textbook Publishing, 2000. 350-439.
3. Cosyns J-P, Jadoul M, Squifflet JP, de Plaen JF, Ferluga D, van Ypersele de Strihou C,. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994; 45: 1680-8. (Pubitemid 24207504)
4. Ivić M,. Etiology of endemic nephropathy. Lijec Vjesn 1969; 91: 1273-81.
5. Hranjec T, Kovač A, Kos J, Wenyang M, Chen JJ, Grollman AP, Jelaković B,. Endemic nephropathy: the case for chronic poisoning by Aristolochia. Croat Med J 2005; 46: 116-25. (Pubitemid 40469936)
6. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 2007; 104: 12129-34. (Pubitemid 47185641)
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC,. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78. (Pubitemid 24289415)
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC,. p53 Mutations in human cancers. Science 1991; 253: 49-53. (Pubitemid 21917115)
9. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC,. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-8. (Pubitemid 21912245)
10. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE,. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993; 90: 4216-20. (Pubitemid 23134197)
11. Arlt VM, Stiborova M, Schmeiser HH,. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002; 17: 265-77. (Pubitemid 34814645)
12. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL,. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342: 1686-92. (Pubitemid 30354515)
13. Nedelko T, Arlt VM, Phillips DH, Hollstein M,. TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours. Int J Cancer 2009; 124: 987-90.
14. Attaluri S, Bonala RR, Yang I-Y, Lukin MA, Wen Y, Grollman AP, Moriya M, Iden CR, Johnson F,. DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells. Nucleic Acids Res 2010; 38: 339-52.
15. National Toxicology Program Report on Carcinogens: Aristolochic Acids, 12th ed. Research Triangle Park, North Carolina: US Dept Health and Human Services, Public Health Service, 2009.
16. Olivier M, Eeles M, Hollstein M, Khan, MA, Harris, CC, Hainaut P,. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002; 19: 607-14. [(R14), November, 2009] (Pubitemid 34556481)
17. Hanawalt PC, Spivak G,. Transcription-coupled DNA repair: two decades of progress and surprises. Nat Rev Mol Cell Biol 2008; 9: 958-70.
18. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L,. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1993; 90: 10529-33. (Pubitemid 23347075)
19. Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J, Rouprêt M,. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. Brit J Urol Int 2009; 104: 1436-40.
20. 2- deoxyguanosine adduct: marked effects of host cell, neighboring base, and chirality. Biochemistry 1996; 35: 16646-51.
21. Arlt VM, Weissler M, Schmeisser HH,. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene. Carcinogenesis 2000; 21: 235-42. (Pubitemid 30098708)
22. Grollman AP, Scarborough J, Jelaković B,. Aristolochic acid nephropathy: an environmental and iatrogenic disease. Adv Mol Toxicol 2009; 3: 211-27.
23. Chen C-Y, Liao Y-M, Tsai W-M, Kuo H-C,. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease. J Formos Med Assoc 2007; 106: 992-8.
24. Hsieh S-C, Lin I-H, Tseng W-L, Lee C-H, Wang J-D,. Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med 2008; 3: 13.
25. Lai M-N, Wang S-M, Chen P-C, Chen Y-Y, Wang J-D,. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 2010; 102: 179-86.